Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Short-term Investments (2016 - 2025)

Elevance Health (ELV) has disclosed Short-term Investments for 17 consecutive years, with $25.9 billion as the latest value for Q4 2025.

  • Quarterly Short-term Investments rose 2.71% to $25.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.9 billion through Dec 2025, up 2.71% year-over-year, with the annual reading at $25.9 billion for FY2025, 2.71% up from the prior year.
  • Short-term Investments for Q4 2025 was $25.9 billion at Elevance Health, up from $1.2 billion in the prior quarter.
  • The five-year high for Short-term Investments was $29.5 billion in Q1 2024, with the low at $165.0 million in Q3 2023.
  • Average Short-term Investments over 5 years is $15.0 billion, with a median of $24.9 billion recorded in 2021.
  • The sharpest move saw Short-term Investments tumbled 99.35% in 2023, then soared 10904.8% in 2024.
  • Over 5 years, Short-term Investments stood at $1.9 billion in 2021, then skyrocketed by 1279.69% to $26.0 billion in 2022, then tumbled by 99.12% to $229.0 million in 2023, then skyrocketed by 10904.8% to $25.2 billion in 2024, then rose by 2.71% to $25.9 billion in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $25.9 billion, $1.2 billion, and $25.3 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.